Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mitoxantrone in relapsed and refractory acute leukemia.

H G Prentice, G Robbins, D D Ma

    Seminars in Oncology
    |September 1, 1984
    PubMed
    Summary

    Mitoxantrone shows promise in treating acute leukemia, with a five-day regimen yielding a 48% response rate. Further studies are needed to confirm its efficacy and safety, particularly cardiac toxicity.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The Europa Imaging System (EIS) Investigation.

    Space science reviews·2024
    Same author

    Rituximab Chimeric Anti-CD20 Monoclonal Antibody Therapy for Relapsed Indolent Lymphoma: Half of Patients Respond to a Four-Dose Treatment Program.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023
    Same author

    An automated approach to determine antibody endpoint titers for COVID-19 by an enzyme-linked immunosorbent assay.

    Immunohematology·2021
    Same author

    [Clinical study of anti-human T cell porcine immunoglobulin with recombinant human tumor necrosis factor-α receptor II: IgG Fc in the treatment of 35 cases of grade III/IV acute graft-versus-host disease after allo-HSCT].

    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi·2020
    Same author

    [Investigation of mental workload and related factors among nurses from tertiary hospitals in Shandong].

    Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases·2020
    Same author

    [A survey on night sleep quality and daytime tiredness among shift nurses in a tertiary teaching hospital].

    Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases·2019

    Area of Science:

    • Oncology
    • Pharmacology

    Background:

    • Mitoxantrone is a synthetic anthracenedione derivative with DNA intercalating properties.
    • In vitro studies demonstrate mitoxantrone induces DNA strand breaks, correlating with leukemia cell line sensitivity.

    Purpose of the Study:

    • To evaluate the efficacy and toxicity of mitoxantrone in patients with relapsed or refractory acute leukemia.
    • To determine the optimal treatment regimen for mitoxantrone in acute leukemia.

    Main Methods:

    • In vitro studies using leukemia cell lines.
    • Clinical trials involving patients with relapsed/refractory acute leukemia, assessing response rates and side effects.

    Main Results:

    • A single infusion of mitoxantrone did not result in complete remission.
    • A five-day treatment regimen achieved a 48% overall response rate, including a 25% complete remission rate.
    • Observed toxicities were limited, primarily alopecia and nausea; cardiac toxicity requires further evaluation.

    Conclusions:

    • Mitoxantrone is a relatively non-toxic agent for acute leukemia treatment.
    • A five-day regimen shows potential efficacy, warranting further investigation in first-line therapy.
    • Ongoing studies aim to establish the role of mitoxantrone in acute leukemia treatment protocols.

    Related Experiment Videos